BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32504410)

  • 21. Dual asymmetric centrifugation as a novel method to prepare highly concentrated dispersions of PEG-b-PCL polymersomes as drug carriers.
    Köthe T; Martin S; Reich G; Fricker G
    Int J Pharm; 2020 Apr; 579():119087. PubMed ID: 32213299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics.
    Gu L; Faig A; Abdelhamid D; Uhrich K
    Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymersomes Based Versatile Nanoplatforms for Controlled Drug Delivery and Imaging.
    Kotha R; Kara DD; Roychowdhury R; Tanvi K; Rathnanand M
    Adv Pharm Bull; 2023 Mar; 13(2):218-232. PubMed ID: 37342386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric polymersomes, from the formation of asymmetric membranes to the application on drug delivery.
    Guo C; Yuan H; Zhang Y; Yin T; He H; Gou J; Tang X
    J Control Release; 2021 Oct; 338():422-445. PubMed ID: 34496272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature-Responsive Polymersomes of Poly(3-methyl-
    Kozlovskaya V; Liu F; Yang Y; Ingle K; Qian S; Halade GV; Urban VS; Kharlampieva E
    Biomacromolecules; 2019 Oct; 20(10):3989-4000. PubMed ID: 31503464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymersomes from Hybrids -Polypeptides for Drug Delivery Applications.
    Iatrou H; Fragouli PG; Skourtis D; Stavropoulou I
    Methods Mol Biol; 2021; 2207():139-150. PubMed ID: 33113133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications.
    Fonseca M; Jarak I; Victor F; Domingues C; Veiga F; Figueiras A
    Materials (Basel); 2024 Jan; 17(2):. PubMed ID: 38255485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymersome carriers: from self-assembly to siRNA and protein therapeutics.
    Christian DA; Cai S; Bowen DM; Kim Y; Pajerowski JD; Discher DE
    Eur J Pharm Biopharm; 2009 Mar; 71(3):463-74. PubMed ID: 18977437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLA-PEG-PLA copolymer-based polymersomes as nanocarriers for delivery of hydrophilic and hydrophobic drugs: preparation and evaluation with atorvastatin and lisinopril.
    Danafar H; Rostamizadeh K; Davaran S; Hamidi M
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1411-20. PubMed ID: 23944838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymersomes: Soft Nanoparticles from Miktoarm Stars for Applications in Drug Delivery.
    Baghbanbashi M; Kakkar A
    Mol Pharm; 2022 Jun; 19(6):1687-1703. PubMed ID: 35157463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymersomes with Rapid K
    You XR; Ju XJ; He F; Wang Y; Liu Z; Wang W; Xie R; Chu LY
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):19258-19268. PubMed ID: 28514157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroneutral polymersomes for combined cancer chemotherapy.
    Aibani N; Nesbitt H; Marino N; Jurek J; O'Neill C; Martin C; Di Bari I; Sheng Y; Logan K; Hawthorne S; McHale A; Callan JF; Callan B
    Acta Biomater; 2018 Oct; 80():327-340. PubMed ID: 30201433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of zwitterionic polymersomes spontaneously formed by pH-sensitive and biocompatible PEG based random copolymers as drug delivery systems.
    Laskar P; Dey J; Ghosh Sk
    Colloids Surf B Biointerfaces; 2016 Mar; 139():107-16. PubMed ID: 26704991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intelligent design of polymersomes for antibacterial and anticancer applications.
    Wang T; Qin J; Cheng J; Li C; Du J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1822. PubMed ID: 35673991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of polypeptide-based polymersomes.
    Zhao L; Li N; Wang K; Shi C; Zhang L; Luan Y
    Biomaterials; 2014 Jan; 35(4):1284-301. PubMed ID: 24211077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High loading of hydrophilic/hydrophobic doxorubicin into polyphosphazene polymersome for breast cancer therapy.
    Xu J; Zhao Q; Jin Y; Qiu L
    Nanomedicine; 2014 Feb; 10(2):349-58. PubMed ID: 23969103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells.
    Nahire R; Haldar MK; Paul S; Ambre AH; Meghnani V; Layek B; Katti KS; Gange KN; Singh J; Sarkar K; Mallik S
    Biomaterials; 2014 Aug; 35(24):6482-97. PubMed ID: 24797878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneously formed redox- and pH-sensitive polymersomes by mPEG based cytocompatible random copolymers.
    Laskar P; Dey J; Ghosh SK
    J Colloid Interface Sci; 2017 Sep; 501():22-33. PubMed ID: 28432913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy.
    Hamidi M; Shahbazi MA; Rostamizadeh K
    Macromol Biosci; 2012 Feb; 12(2):144-64. PubMed ID: 22006795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.